DIO2 and obesity due to melanocortin 4 receptor deficiency: However, neonatal hepatocyte-specific Dio2-KO impaired response to HFD, resulting in alteration of lipid metabolism and PPARy expression, as well as lower rate of obesity and hepatic steatosis [208].